The breast cancer drug tamoxifen may reduce some of the side effects caused by hormone therapy for prostate cancer, according to a new study. German researchers examined the results of four independent clinical trials that examined the use of tamoxifen to manage side effects in prostate cancer patients undergoing androgen-suppression therapy. The study found that tamoxifen reduced the risk of breast enlargement and breast pain in men at three, six, nine and 12 months of treatment compared to men who did not take tamoxifen. Overall, tamoxifen was more successful in reducing breast symptoms than radiation therapy or treatment with the aromatase inhibitor anastrozole, which is also used to treat breast cancer. Read more here.
Study mentioned: Kunath F, et al. Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: A systematic review. BMC Med. 2012 Aug 28;10(1):96. [Epub ahead of print] PMID: 22925442
No comments:
Post a Comment